[HTML][HTML] Sialylation as an important regulator of antibody function

R Vattepu, SL Sneed, RM Anthony - Frontiers in Immunology, 2022 - frontiersin.org
Antibodies play a critical role in linking the adaptive immune response to the innate immune
system. In humans, antibodies are categorized into five classes, IgG, IgM, IgA, IgE, and IgD …

Getting Syk: spleen tyrosine kinase as a therapeutic target

RL Geahlen - Trends in pharmacological sciences, 2014 - cell.com
Spleen tyrosine kinase (Syk) is a cytoplasmic protein tyrosine kinase well known for its
ability to couple immune cell receptors to intracellular signaling pathways that regulate …

[HTML][HTML] The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab

P Gasser, SS Tarchevskaya, P Guntern… - Nature …, 2020 - nature.com
Targeting of immunoglobulin E (IgE) represents an interesting approach for the treatment of
allergic disorders. A high-affinity monoclonal anti-IgE antibody, ligelizumab, has recently …

[HTML][HTML] IgE antibodies: from structure to function and clinical translation

BJ Sutton, AM Davies, HJ Bax, SN Karagiannis - Antibodies, 2019 - mdpi.com
Immunoglobulin E (IgE) antibodies are well known for their role in mediating allergic
reactions, and their powerful effector functions activated through binding to Fc receptors …

Roles of omalizumab in various allergic diseases

Y Okayama, H Matsumoto, H Odajima… - Allergology …, 2020 - jstage.jst.go.jp
abstract IgE and mast cells play a pivotal role in various allergic diseases, including asthma,
allergic rhinitis, and urticaria. Treatment with omalizumab, a monoclonal anti-IgE antibody …

Human IgG4: a structural perspective

AM Davies, BJ Sutton - Immunological Reviews, 2015 - Wiley Online Library
IgG4, the least represented human IgG subclass in serum, is an intriguing antibody with
unique biological properties, such as the ability to undergo Fab‐arm exchange and limit …

[HTML][HTML] IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms

BS Kuo, CH Li, JB Chen, YY Shiung… - The Journal of …, 2023 - Am Soc Clin Investig
Over the last 2 decades, omalizumab is the only anti-IgE antibody that has been approved
for asthma and chronic spontaneous urticaria (CSU). Ligelizumab, a higher-affinity anti-IgE …

The role of CD23 in the regulation of allergic responses

P Engeroff, M Vogel - Allergy, 2021 - Wiley Online Library
IgE, the key molecule in atopy has been shown to bind two receptors, FcεRI, the high‐affinity
receptor, and FcεRII (CD23), binding IgE with lower affinity. Whereas cross‐linking of IgE on …

Structure and dynamics of IgE–receptor interactions: Fcε RI and CD 23/Fcε RII

BJ Sutton, AM Davies - Immunological reviews, 2015 - Wiley Online Library
Immunoglobulin E (IgE) is well known for its role in allergic disease, the manifestations of
which are mediated through its two Fc receptors, Fcε RI and CD 23 (Fcε RII). IgE and its …

Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches?

ST Holgate - Journal of Allergy and Clinical Immunology, 2011 - Elsevier
Current asthma therapy is based on the use of adrenergic bronchodilator and anti-
inflammatory drugs the specificity, efficacy, duration of action, and safety of which have been …